Published in J Dairy Res on August 01, 1986
Salivaricin A2 and the novel lantibiotic salivaricin B are encoded at adjacent loci on a 190-kilobase transmissible megaplasmid in the oral probiotic strain Streptococcus salivarius K12. Appl Environ Microbiol (2006) 1.36
DNA fingerprinting of Streptococcus uberis: a useful tool for epidemiology of bovine mastitis. Epidemiol Infect (1989) 1.35
First insights into the evolution of Streptococcus uberis: a multilocus sequence typing scheme that enables investigation of its population biology. Appl Environ Microbiol (2006) 1.35
Molecular and genetic characterization of a novel nisin variant produced by Streptococcus uberis. Appl Environ Microbiol (2006) 1.35
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions. Epidemiol Infect (1991) 1.09
Molecular epidemiology of Streptococcus uberis isolates from dairy cows with mastitis. J Clin Microbiol (2001) 1.02
Ubericin A, a class IIa bacteriocin produced by Streptococcus uberis. Appl Environ Microbiol (2007) 0.80
Inverse correlation in nutritionally variant streptococci between the production of bacteriolytic activity and sensitivity to a Streptococcus pyogenes bacteriocinlike inhibitory substance. J Clin Microbiol (1991) 0.75
Bacteriocins of gram-positive bacteria. Bacteriol Rev (1976) 10.66
Bacteriocins of gram-positive bacteria. Microbiol Rev (1995) 7.68
Assay system for bacteriocins. Appl Microbiol (1971) 3.05
Dental caries is a preventable infectious disease. Aust Dent J (2000) 1.98
"Fingerprinting" beta-haemolytic streptococci by their production of and sensitivity to bacteriocine-like inhibitors. J Med Microbiol (1979) 1.97
Group A streptococcal bacteriocin. Production, purification, and mode of action. J Exp Med (1973) 1.89
Processing of the gp55-116 envelope glycoprotein complex (gB) of human cytomegalovirus. J Virol (1989) 1.68
Intra- and interspecies signaling between Streptococcus salivarius and Streptococcus pyogenes mediated by SalA and SalA1 lantibiotic peptides. J Bacteriol (2001) 1.63
Bacteriocin of a group B streptococcus: partial purification and characterization. Antimicrob Agents Chemother (1975) 1.59
Isolation and characterization of the lantibiotic salivaricin A and its structural gene salA from Streptococcus salivarius 20P3. Appl Environ Microbiol (1993) 1.56
Bacteriocin of a group A streptococcus: partial purification and properties. Antimicrob Agents Chemother (1973) 1.54
A preliminary study of the effect of probiotic Streptococcus salivarius K12 on oral malodour parameters. J Appl Microbiol (2006) 1.54
Oligomerization of the human cytomegalovirus major envelope glycoprotein complex gB (gp55-116). J Virol (1992) 1.42
Cloning of the gene encoding Streptococcin A-FF22, a novel lantibiotic produced by Streptococcus pyogenes, and determination of its nucleotide sequence. Appl Environ Microbiol (1993) 1.36
Two-component anti-Staphylococcus aureus lantibiotic activity produced by Staphylococcus aureus C55. Appl Environ Microbiol (1998) 1.29
Haemolysin-deficient variants of Streptococcus pyogenes and S. dysgalactiae subsp. equisimilis may be overlooked as aetiological agents of pharyngitis. J Med Microbiol (2000) 1.24
Characterization of Streptococcus zooepidemicus (Lancefield group C) from human and selected animal infections. Epidemiol Infect (1987) 1.16
Evaluation of safety and human tolerance of the oral probiotic Streptococcus salivarius K12: a randomized, placebo-controlled, double-blind study. Food Chem Toxicol (2011) 1.13
Novel lantibiotics and their pre-peptides. Antonie Van Leeuwenhoek (1996) 1.12
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 1. Pyocine typing of Ps. aeruginosa. Med J Aust (1971) 1.12
Genotypic and phenotypic analysis of Streptococcus uberis isolated from bovine mammary secretions. Epidemiol Infect (1991) 1.09
A lantibiotic gene family widely distributed in Streptococcus salivarius and Streptococcus pyogenes. Dev Biol Stand (1995) 1.09
Preliminary investigations of the colonisation of upper respiratory tract tissues of infants using a paediatric formulation of the oral probiotic Streptococcus salivarius K12. Eur J Clin Microbiol Infect Dis (2008) 1.08
Production of a bacteriocine-like substance by group-A streptococci of M-type 4 and T-pattern 4. J Med Microbiol (1979) 1.06
Bacteriocin-like activity of group B and group C streptococci of human and of animal origin. J Hyg (Lond) (1983) 1.04
Different bacteriocin activities of Streptococcus mutans reflect distinct phylogenetic lineages. J Med Microbiol (2002) 1.04
Streptococcus mutans strain N produces a novel low molecular mass non-lantibiotic bacteriocin. FEMS Microbiol Lett (2000) 1.03
Application of inhibitor typing in a study of the transmission and retention in the human mouth of the bacterium Streptococcus salivarius. Arch Oral Biol (1983) 1.03
Factors affecting production of the group A streptococcus bacteriocin SA-FF22. J Med Microbiol (1992) 1.03
Genetic basis of streptococcin A-FF22 production. Antimicrob Agents Chemother (1976) 1.02
The production of bacteriocin-like substances by the oral bacterium Streptococcus salivarius. Arch Oral Biol (1982) 1.00
Some possible autoimmune mechanisms in rheumatic carditis. Lancet (1972) 0.99
Transduction of bacteriocin determinants in group A streptococci. J Exp Med (1976) 0.99
Salivaricin 9, a new lantibiotic produced by Streptococcus salivarius. Microbiology (2011) 0.97
The rationale and potential for the reduction of oral malodour using Streptococcus salivarius probiotics. Oral Dis (2005) 0.97
Streptococcin A-FF22: nisin-like antibiotic substance produced by a group A streptococcus. Antimicrob Agents Chemother (1978) 0.97
Inhibitor production by group-G streptococci of human and of animal origin. J Med Microbiol (1983) 0.95
M-type 57 group A streptococcus bacteriocin. Can J Microbiol (1983) 0.95
Identification of genes encoding two-component lantibiotic production in Staphylococcus aureus C55 and other phage group II S. aureus strains and demonstration of an association with the exfoliative toxin B gene. Infect Immun (1999) 0.95
Mode of action of a lysostaphin-like bacteriolytic agent produced by Streptococcus zooepidemicus 4881. Appl Environ Microbiol (1996) 0.92
Beneficial microbes for the oral cavity: time to harness the oral streptococci? Benef Microbes (2011) 0.92
Lantibiotic-mediated anti-lactobacillus activity of a vaginal Staphylococcus aureus isolate. FEMS Microbiol Lett (1992) 0.91
Role of bacteriocin during plaque formation by Streptococcus salivarius and Streptococcus sanguis on a tooth in an artificial mouth. J Appl Bacteriol (1981) 0.90
Production of bacteriocin-like inhibitors by group A streptococci of nephritogenic M types. J Clin Microbiol (1984) 0.89
Use of an inhibitor typing scheme to study the epidemiology of Streptococcus uberis mastitis. N Z Vet J (1988) 0.88
Suspected periodontopathic microorganisms and their oral habitats in young children. Oral Microbiol Immunol (1987) 0.88
Antiviral antibody responses in mothers and their newborn infants with clinical and subclinical congenital cytomegalovirus infections. J Infect Dis (1990) 0.87
Bacteriocin production by group a streptococcal L-forms. Antimicrob Agents Chemother (1976) 0.87
Production of broad-spectrum bacteriocin-like activity by group A streptococci of particular M-types. Zentralbl Bakteriol Mikrobiol Hyg A (1985) 0.87
Bacteriocin-like inhibitory activity associated with beta-hemolytic strains of Streptococcus salivarius. J Dent Res (1987) 0.86
Morphological changes in a susceptible strain of Streptococcus pyogenes treated with streptocin A. J Gen Microbiol (1973) 0.86
Bacteriocin production and sensitivity among coaggregating and noncoaggregating oral streptococci. Oral Microbiol Immunol (1997) 0.84
Genetic basis for mutacin N and of its relationship to mutacin I. Indian J Med Res (2004) 0.84
Proteinase-related broad-spectrum inhibitory activity among group-A streptococci. J Med Microbiol (1986) 0.84
Epidemiology of Pseudomonas aeruginosa infection in hospitals. 2. "Fingerprinting" of Ps. aeruginosa strains in a study of cross-infection in a children's hospital. Med J Aust (1971) 0.83
A bacteriocin produced by certain M-type 49 Streptococcus pyogenes strains when incubated anaerobically. J Hyg (Lond) (1984) 0.83
A new alkaline pH-adjusted medium enhances detection of beta-hemolytic streptococci by minimizing bacterial interference due to Streptococcus salivarius. J Clin Microbiol (2000) 0.82
Heart-reactive antibodies in rheumatic fever. Med J Aust (1972) 0.82
High pharyngeal carriage rates of Streptococcus pyogenes in Dunedin school children with a low incidence of rheumatic fever. N Z Med J (2000) 0.81
Pyocine typing as an epidemiological marker in Pseudomonas aeruginosa mastitis in cattle. J Hyg (Lond) (1971) 0.81
Relationship of bacteriocin-like inhibitor production to the pigmentation and hemolytic activity of mutans streptococci. Zentralbl Bakteriol Mikrobiol Hyg A (1987) 0.80
Suspected periodontopathic bacteria associated with broken-mouth periodontitis in sheep. J Periodontal Res (1988) 0.80
Microbially-produced peptides having potential application to the prevention of dental caries. Int J Antimicrob Agents (1997) 0.79
The prevention of dental caries by BLIS-mediated inhibition of mutans streptococci. N Z Dent J (1991) 0.78
Bacteriocin production by Streptococcus salivarius strain P. Can J Microbiol (1981) 0.78
Structural and immunological characterization of human cytomegalovirus gp55-116 (gB) expressed in insect cells. J Gen Virol (1990) 0.78
Evaluation of a typing scheme for group A streptococci based upon bacteriocin-like inhibitor production. Zentralbl Bakteriol Mikrobiol Hyg A (1984) 0.77
Pyocin-sensitivity testing as a means of typing Pseudomonas aeruginosa. J Med Microbiol (1973) 0.77
Myoid cell antibody in rheumatic fever. Immunol Commun (1973) 0.77
Evaluation of stored lamb bio-preserved using a three-strain cocktail of Lactobacillus sakei. Meat Sci (2010) 0.77
Diverse activity spectra of bacteriocin-like inhibitory substances having activity against mutans streptococci. Caries Res (2001) 0.77
Black-pigmented Bacteroides associated with broken-mouth periodontitis in sheep. J Periodontal Res (1987) 0.77
Role of proteinase in the formation of inhibitory levels of hematin by group A streptococcus cultures on blood-containing media. J Clin Microbiol (1986) 0.75
Environmental influences on the progression of clinical and microbiological parameters of sheep periodontal disease. Res Vet Sci (1989) 0.75
An inhibitor typing scheme applicable to Lancefield group E streptococci. Can J Microbiol (1985) 0.75
Streptolysin S: purification and properties. Zentralbl Bakteriol Orig A (1978) 0.75
Toxic shock syndrome. N Z Med J (1987) 0.75
Bacterial interference and toxic shock syndrome. Ann Intern Med (1983) 0.75
Incidence and characterization of anti-microbial effects produced by Actinomyces viscosus and Actinomyces naeslundii. J Dent Res (1986) 0.75
Commensal bacilli inhibitory to mastitis pathogens isolated from the udder microbiota of healthy cows. J Appl Microbiol (2006) 0.75
Quantification of the bacterium Bacteroides gingivalis in human dental plaque by detection of the trypsin-like protease activity of colonies imprinted on membrane filters. Arch Oral Biol (1987) 0.75